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Introduction: Carcinoid tumors are neuroendocrine malignancies that originate in the neu-
roectodermal cells of the Amine, Peptide Uptake and Decarboxylation system dispersed in
the gastrointestinal mucosa and representing about 80–88% of tumors of cecal appendix.
These  are tumors usually diagnosed at appendectomies, and it is estimated that from each
100  appendectomies yearly performed, at least one case is a neuroendocrine tumor.
Objectives: To report the experience of an University Teaching Hospital in health and refer-
ence  at the east side of São Paulo and great São Paulo in cases of these rare appendicular
tumors,  with emphasis on the importance of these descriptions, as probably are rare those
surgeons  in particular who will acquire extensive wisdom in these cases.
Method:  Retrospective analysis of 237 patients who underwent appendectomy from Septem-
ber  2010 to September 2012 in the Hospital Santa Marcelina-SP. We  evaluated data on age,
gender,  initial clinical presentation and surgical ﬁndings of patients undergoing appendec-
tomy  with subsequent anatomic and immunopathological diagnosis of carcinoid tumor of
cecal appendix.
Results: The presence of a carcinoid tumor of the appendix was observed in 5 patients,which  corresponds to 2.1% of all appendectomies performed. Regarding gender, 4 patients
(80%)  were female and the average age was 34.2 years, with a range from 17 to 68 years.
In  all patients the initial hypothesis for surgery indication was acute appendicitis, with an
intraoperative ﬁnding of necroperforated phase acute appendicitis in 3 patients (60%). Study conducted at the Coloproctology Medical Residency Program, Department of General Surgery, Hospital Santa Marcelina, São
aulo, SP, Brazil.
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Conclusion: The therapeutical conduct after the diagnosis of carcinoid tumors of the
appendix must be based on the data provided by pathological and immunohistochemical
studies,  besides the judicious judgment of the attending physician.
©  2014 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. 
Tumor  Carcinoide  de  Apêndice  Cecal:  incidência  em  um  ano  no  Hospital
Santa  Marcelina
Palavras-chave:
Apendicite aguda
Tumor  carcinoide de apêndice
Conduta
Seguimento
r  e  s  u  m  o
Introduc¸ão: Os tumores carcinoides são neoplasias malignas neuroendócrinas que se
originam em células neuroectodérmicas do sistema APUD (Amine, Peptide Uptake and Decar-
boxylation), dispersas na mucosa gastrointestinal e que representam cerca de 80-88% das
neoplasias do apêndice cecal. São tumores diagnosticados geralmente durante apendicec-
tomias e estima-se que de cada 100 apendicectomias realizadas por ano, ao menos um caso
será TNE.
Objetivos: Objetiva-se nesse artigo relatar experiência de Hospital Universitário e de Ensino
(HUE) em saúde e referência na zona leste de São Paulo e grande São Paulo em casos
desses raros tumores apendiculares, com ênfase na importância dessas descric¸ões,  já que
provavelmente raros cirurgiões em particular irão adquirir uma  extensa sapiência nesses
casos.
Método: Análise retrospectiva de 237 pacientes submetidos à apendicectomia no período de
setembro de 2010 a setembro de 2012 no Hospital Santa Marcelina-SP. Foram avaliados os
dados referentes a idade, sexo, quadro clínico inicial, achados operatórios dos pacientes sub-
metidos à apendicectomia com posterior diagnóstico anatomopatológico e imunopatológico
de tumor carcinoide de apêndice.
Resultados:  Veriﬁcou-se a presenc¸a  de tumor carcinoide de apêndice em 5 pacientes, o que
corresponde a 2,1% das apendicectomias realizadas. Com relac¸ão  ao gênero, 4 pacientes
(80%) eram mulheres e a média de idade foi de 34,2 anos, com variac¸ão  de 17 a 68 anos. Em
todos os pacientes a hipótese inicial para indicac¸ão  de cirurgia fora de apendicite aguda,
com achado intra-operatório de apendicite aguda em fase necroperfurada em 3 pacientes
(60%).
Conclusão: A conduta após o diagnóstico de tumores carcinoides de apêndice cecal deve
ser alicerc¸ada  nos dados fornecidos por exames anatomopatológicos e imunoistoquímicos,
além  do julgamento criterioso do médico assistente.
©  2014 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Este é um artigo Open Access sob a licença de CC BY-NC-ND
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Recognized since the late nineteenth century and receiving
the  designation “karzinoid” only in 1917 by Oberndorfer,1,2 car-
cinoid  tumors are neuroendocrine malignancies that originate
in  neuroectodermal cells of the APUD (Amine, Peptide Uptake
and  Decarboxylation) system, dispersed in the gastrointesti-
nal  mucosa and representing about 80–88% of tumors of the
appendix.3,4
The appendix is the second most frequent site of onset
of  neuroendocrine tumors (NET) throughout the digestive
tract,  with a frequency of 25–30%,5 after tumors of the
small  intestine.6,7 Usually these tumors are diagnosed during
appendectomies, and it is estimated that at each 100 appen-
dectomies  performed yearly, at least one case is NET.8 Others,
like  Fernando et al., demonstrate an incidence of 0.3–0.7% of
the  histopathological ﬁndings in appendectomies.9The approximate incidence of this neoplasm is 2–3 cases
per  million, with a preference for females of 2–4:1,10 but with
no  race predilection. The peak incidence is between 15 and 19
years  in women and 20–24 years in men.10
The preoperative diagnosis of a malignant neoplasm of the
appendix  is rarely performed because of its nonspeciﬁc clini-
cal  picture, often compatible with an acute appendicitis.11
As for treatment, considering that the diagnosis is usually
established by the pathologist during the postoperative period,
it  is up to the surgeon the task, sometimes hard, to determine,
through the pathology report (basically analyzing tumor size
and  its location in the appendix, the patient’s age and presence
of  metastases), if the patient will be treated with a second
surgical intervention, this time of a more  aggressive type, in
the  form of right hemicolectomy.
This  study aims to relate the experience of an University
Teaching Hospital (HTH) in health and reference on the east
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Table 1 – Age, localization data, tumor size and
immunohistochemistry of the carcinoid tumor and cecal
appendix  operations.
Name Age Size Location Ki67
AFFS 17 years 7 mm Basal No data available
NF 50 years 1 mm Basal Inconclusive
LEA 17 years 9 mm Extremity 1%
TRLM 19 years 7 mm Basal <1%j coloproctol (rio j). 
ide of São Paulo and greater São Paulo in those rare cases
f  appendicular tumors, with emphasis on the importance of
hese  descriptions, considering that probably few surgeons in
articular will acquire an extensive experience in these cases.
atients  and  methods
his is a retrospective analysis of 237 patients who underwent
ppendectomy from September 2010 to September 2012 in the
ospital  Santa Marcelina-SP.
Data  for age, gender, baseline clinical picture, surgical ﬁnd-
ngs  of patients undergoing appendectomy, with subsequent
natomical and immunopathological diagnosis of carcinoid
umor  of the appendix were evaluated. In this search, we stud-
ed  data on macroscopic location of the tumor and its size,
s  well as its histopathologic features. Regarding immuno-
istochemistry, we  analyzed positive tumor markers and Ki67
ndex.
Next, additional tests were performed in order to achieve a
etter  tumor staging and for the approach to be adopted, with
ubsequent  follow-up and clinical outcome analysis.
esults
uring the study period between September 2010 and
eptember 2012, 237 appendectomies were performed at the
epartment  of general surgery, Hospital Santa Marcelina, São
aulo. Of this total, carcinoid tumor of the appendix was
iagnosed in 5 patients, which corresponds to 2.1% of all
ppendectomies performed (Fig. 1).
It is worth noting that all patients were  referred to the colo-
roctology outpatient clinic, and one of these patients came
rom  an external service.
As  to the gender, 4 patients (80%) were female and the
verage age was  34.2 years, with a range of 17–68 years. In
ll  patients the initial hypothesis for indication of surgery
ad  been acute appendicitis, with an intraoperative ﬁnding of
ecroperforated-stage acute appendicitis in 3 patients (60%)
Pathological resultCarcinoid
tumor
2%
Appendicitis
98%
ig. 1 – Percentage of carcinoid tumors by pathological
iagnosis after appendectomy.SAD 68 years 6 mm Extremity <1%
and phlegmonous-stage acute appendicitis in two patients
(40%).
Table  1 shows data regarding pathological and immunohis-
tochemistry examinations.
A  conduct of right hemicolectomy was adopted in two
patients and watchful waiting for the other three; the surgical
choices  were  due to the fact that, in the ﬁrst patient, a mas-
sive  mesoappendix invasion was  observed; and in the second
patient,  the immunohistochemistry report was inconclusive
for  deﬁning tumor histogenesis.
Discussion
Carcinoid tumors are neoplasms of the diffuse neuroen-
docrine cell system with genetic involvement in its etiology,
with  possible deletion of the gene PLC3 and consequent
uncontrolled growth of neuroendocrine cells, distortion of the
apoptosis  process and development of neoplasms.12,13
The ﬁve cases of carcinoid tumor of the appendix described
in  this study present an incidence of 2.1% of the total of
237  appendectomies performed in the period of two years at
the  Hospital Santa Marcelina, coincident with the incidence
described in the literature.11
Importantly, malignant neoplasms of the appendix, regard-
less  of histological type, are presented most of the time
with  a clinical picture highly suggestive of acute appendicitis
(about 68%), probably due to the obstruction of the appen-
diceal  lumen by the neoplastic injury, causing an overlapping
infection.14,15 In none of the cases here reported a preoper-
atory suspicion of cancer of the appendix was  raised; and
in  all reports the initial hypothesis was  acute appendicitis,
although in one patient (NF) the medical history with its evolu-
tion  time of ﬁve days did not match the physical examination.
The  deﬁnitive diagnosis of neoplasia and its histologic type
are  conﬁrmed only by histological and immunopathological
studies of the surgical specimen.
Consistent with the literature,4 in the present study a
higher  incidence of neuroendocrine tumor (NET) of the
appendix was  found in females, with 80% of cases (4/5), and
with  a higher prevalence in young patients, with a mean age
of  43.2 years. Large series in the literature indicate that the
mean  age ranged from 27 to 40 years.10
With respect to carcinoid tumors of the appendix, the most
frequent  location is at its extremity in 62–78% of cases; and
generally  between 70 and 95% of the tumors measure less than
1  cm.16,17 More  speciﬁcally, Roggo et al.14 report that 80% of
their  patients’ tumors were  smaller than 1 cm,  14% between 1
and 2 cm,  and 6% larger than 2 cm.  In this study, all cases of
248  j coloproctol (rio j). 2 0
Table 2 – Histological grade based on the mitosis
number and Ki67 percentage.
Histological grade Mitosis number Ki67
Grade I <2 mitoses/10 ﬁelds <2%
Grade II 2–20 mitoses/10 ﬁelds 2–20%
Grade III >20 mitoses/10 ﬁelds >20%
Table 3 – TNM staging of carcinoid tumor of the
appendix.
T-primary tumor
Tx  A primary tumor cannot be assessed
T0 No evidence of primary tumor
T1 Tumor ≤1 cm invading submucosa and
muscularis propria
T2  Tumor ≤2 cm invading submucosa,
muscularis propria and/or minimal serosal or
mesoappendiceal invasion (up to 3 mm)
T3  Tumor >2 cm and/or massive serosal or
mesoappendiceal invasion (>3 mm)
T4 Tumor invading peritoneum/other organs
N-regional lymph nodes
Nx  Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Presence of regional lymph node metastasis
M-Metastasis
Mx A distant metastasis cannot be assessed
M0 No distant metastasis
M1  Presence of distant metastasis
Table 4 – Clinical staging.
Clinical
stage
T-primary
tumor
N-lymph
nodes
M-metastasis
I T1 N0 M0
IIA T2 N0 M0
IIB T3 N0 M0
IIIA T4 N0 M0
IIIB Any T N1 M0
r
1989;42:1169–72.IV Any T Any N M1
carcinoid tumors measured less than 1 cm,  and 40% of them
were  located at the extremity of the appendix.
Recent consensus established by the European Neuroen-
docrine Tumor Society (ENETS) proposes a grading system
for  NETs of the stomach, duodenum and pancreas, based on
mitotic  count and/or immunohistochemical assessment of
Ki67,  a proliferation marker (Table 2).18
Another model widely used for carcinoid tumor of the
appendix staging is that also proposed by ENETS in 2007 and
presented  in Tables 3 and 4.19
Surgical resection is the most widely established treat-
ment  for patients with carcinoid tumor of the appendix. It is
known that, for lesions smaller than 1 cm,  the appendectomy
achieves high cure rates (near 100%). In tumors measuring
between 1 and 2 cm and without lymph node involvement,
the appendectomy is also indicated. If there is lymph node
involvement, it becomes necessary a procedure of right hemi-
colectomy,  although presenting metastases around 3%. In
patients  with tumors larger than 3 cm,  right hemicolectomy 1 4;3  4(4):245–249
also is the best therapeutic option, but with a high rate of
metastases (about 80%).20,21 To these indications, we  must also
add  the cases with mesoappendix invasion.22
Furthermore, some indications for a more  aggressive inter-
vention,  besides the diameter of the mass, are the extent of
the  mesoappendix tumor, its location at the base of appendix,
subserosal lymphatic invasion, and age of the patient. These
criteria  for a broader surgery have greater signiﬁcance when
deciding  between an appendectomy or a right hemicolectomy
in  patients with tumors with 1–2 cm.23
Also with respect to prognosis, It is known that the risk of
metastasis  in tumors measuring less than 1 cm in diameter is
zero; for tumors of 1–2 cm,  this risk is 0–11%; and in tumors
larger than 2 cm,  the risk of metastasis is considerably higher,
30–60%.11
Study conducted by the Abdominal-Pelvic Surgery Service
at  INCA5 evaluated 13 patients operated at, or referenced
to,  that institution between 1996 and 2008. A predominance
of female patients (5.5:1) was noted, with a mean age of
44.7  years. The tumor size ranged from 0.3 to 6 cm,  with a
median  of 2.3 cm;  and in two cases the patients have started
the  disease with a distant lesion. Furthermore, it was shown
that,  after a mean follow-up of 32 months, 10 patients were
alive  (77%), one (7.7%) was  lost to follow-up, and two (15.3%)
died.
Conclusion
The medical conduct after the diagnosis of a carcinoid tumor
of  the appendix must be based in data provided by patholog-
ical  and immunohistochemical studies, besides the judicious
judgment of the treating physician. In addition (and also
because  this tumor mainly affects relatively young indi-
viduals),  we  must proceed with the oncological follow-up,
despite adopting a conservative approach, since these patients
present  an increased risk of synchronous or metachronous
malignancies in percentages that can reach 29%, par-
ticularly in the gastrointestinal tract, breast, cervix and
endometrium.
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